1. Kuzneetsov VV. Diagnosis of metastatic skeletal lesions. Tyumenskii meditsinskii zhurnal. 2013;15(4):30-2. (In Russ.)
2. Kalabaeva MK, Saduakasova AB, Mukazhanova MU, Lyugai EA. Determination of the optimal dose ratio cocktails of radiopharmaceuticals 18F-NaF and 18F-FDG Based on the diagnosis of visceral and bone metastatic lesions PET/CT studies. Diagnostic radiology and radiotherapy= Luchevaya diagnostika i terapiya. 2017;8(3):82-83. (In Russ.). Accessed 03.02.2021. https://elibrary.ru/item.asp?id=30148443
3. Saduakasova AB, Kalabaeva MK. Comparative analysis of radiopharmaceuticals for diagnostic radioisotope bone metastases of breast cancer and prostate cancer: 99mTc-MDP during a bone scan and 18F-NaF PET/CT study. Diagnostic radiology and radiotherapy=Luchevaya diagnostika i terapiya. 2017;8(3):85. (In Russ.). Accessed 03.02.2021. https://elibrary.ru/item.asp?id=30148448
4. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer
5. Osteotropic radiopharmaceuticals in Russian nuclear medicine techniques